|
|
 Previous Article | Table of Contents | Next Article 
Blood, 15 November 2000, Vol. 96, No. 10, pp. 3499-3504
IMMUNOBIOLOGY
A subset of human monocyte-derived dendritic cells expresses high
levels of interleukin-12 in response to combined CD40
ligand and interferon- treatment
Paul J. Mosca,
Amy C. Hobeika,
Timothy M. Clay,
Smita K. Nair,
Elaine K. Thomas,
Michael A. Morse, and
H. Kim Lyerly
From the Departments of General and Thoracic Surgery,
Pathology, Immunology, and Internal Medicine, Center for Genetic and
Cellular Therapies, Duke University Medical Center, Durham, NC; and
Immunex Inc, Seattle, WA.
Dendritic cells (DCs) may arise from multiple lineages and progress
through a series of intermediate stages until fully mature, at which
time they are capable of optimal antigen presentation and T-cell
activation. High cell surface expression of CD83 is presumed to
correlate with full maturation of DCs, and a number of agents have been
shown to increase CD83 expression on DCs. We hypothesized that
interleukin 12 (IL-12) expression would be a more accurate marker of
functionally mature DCs capable of activating antigen-specific T cells.
We used combinations of signaling through CD40, using CD40 ligand
trimer (CD40L), and interferon gamma to demonstrate that CD83
expression is necessary but not sufficient for optimal production of
IL-12 by DCs. Phenotypically mature DCs could be induced to produce
high levels of IL-12 p70 only when provided 2 simultaneous stimulatory
signals. By intracellular cytokine detection, we determined that only a
subset of cells that express high levels of CD80 and CD83 generate
large amounts of IL-12. DCs matured with both signals are superior to
DCs stimulated with the individual agents in activating
antigen-specific T cell in vitro. These findings have important
implications regarding the identification, characterization, and
clinical application of functionally mature DCs.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
P. Mukherjee and V. S. Chauhan
Plasmodium falciparum-free merozoites and infected RBCs distinctly affect soluble CD40 ligand-mediated maturation of immature monocyte-derived dendritic cells
J. Leukoc. Biol.,
July 1, 2008;
84(1):
244 - 254.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Frasca, M. Nasso, F. Spensieri, G. Fedele, R. Palazzo, F. Malavasi, and C. M. Ausiello
IFN-{gamma} Arms Human Dendritic Cells to Perform Multiple Effector Functions
J. Immunol.,
February 1, 2008;
180(3):
1471 - 1481.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. S. Kornbluth and G. W. Stone
Immunostimulatory combinations: designing the next generation of vaccine adjuvants
J. Leukoc. Biol.,
November 1, 2006;
80(5):
1084 - 1102.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-S. Yoon, J. S. Lee, B.-M. Choi, Y.-I. Jeong, C.-M. Lee, J.-H. Park, Y. Moon, S.-C. Sung, S. K. Lee, Y. H. Chang, et al.
Apigenin Inhibits Immunostimulatory Function of Dendritic Cells: Implication of Immunotherapeutic Adjuvant
Mol. Pharmacol.,
September 1, 2006;
70(3):
1033 - 1044.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Dauer, K. Schad, J. Junkmann, C. Bauer, J. Herten, R. Kiefl, M. Schnurr, S. Endres, and A. Eigler
IFN-{alpha} promotes definitive maturation of dendritic cells generated by short-term culture of monocytes with GM-CSF and IL-4
J. Leukoc. Biol.,
August 1, 2006;
80(2):
278 - 286.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Tada, S. Aiba, K.-I. Shibata, T. Ohteki, and H. Takada
Synergistic Effect of Nod1 and Nod2 Agonists with Toll-Like Receptor Agonists on Human Dendritic Cells To Generate Interleukin-12 and T Helper Type 1 Cells
Infect. Immun.,
December 1, 2005;
73(12):
7967 - 7976.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Osada, M. A. Morse, H. K. Lyerly, and T. M. Clay
Ex vivo expanded human CD4+ regulatory NKT cells suppress expansion of tumor antigen-specific CTLs
Int. Immunol.,
September 1, 2005;
17(9):
1143 - 1155.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Yang, K.-Y. Tsang, and J. Schlom
Induction of Higher-Avidity Human CTLs by Vector-Mediated Enhanced Costimulation of Antigen-Presenting Cells
Clin. Cancer Res.,
August 1, 2005;
11(15):
5603 - 5615.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Morse, T. M. Clay, A. C. Hobeika, T. Osada, S. Khan, S. Chui, D. Niedzwiecki, D. Panicali, J. Schlom, and H. K. Lyerly
Phase I Study of Immunization with Dendritic Cells Modified with Fowlpox Encoding Carcinoembryonic Antigen and Costimulatory Molecules
Clin. Cancer Res.,
April 15, 2005;
11(8):
3017 - 3024.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Bedrosian, R. Mick, S. Xu, H. Nisenbaum, M. Faries, P. Zhang, P. A. Cohen, G. Koski, and B. J. Czerniecki
Intranodal Administration of Peptide-Pulsed Mature Dendritic Cell Vaccines Results in Superior CD8+ T-Cell Function in Melanoma Patients
J. Clin. Oncol.,
October 15, 2003;
21(20):
3826 - 3835.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Crawford, A. Stark, B. Kitchens, K. Sternheim, V. Pantazopoulos, E. Triantafellow, Z. Wang, B. Vasir, C. E. Larsen, D. Gabuzda, et al.
CD2 engagement induces dendritic cell activation: implications for immune surveillance and T-cell activation
Blood,
September 1, 2003;
102(5):
1745 - 1752.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Tschoep, T. C. Manning, H. Harlin, C. George, M. Johnson, and T. F. Gajewski
Disparate functions of immature and mature human myeloid dendritic cells: implications for dendritic cell-based vaccines
J. Leukoc. Biol.,
July 1, 2003;
74(1):
69 - 80.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Messmer, B. Messmer, and N. Chiorazzi
The global transcriptional maturation program and stimuli-specific gene expression profiles of human myeloid dendritic cells
Int. Immunol.,
April 1, 2003;
15(4):
491 - 503.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A.-S. Charbonnier, H. Hammad, P. Gosset, G. A. Stewart, S. Alkan, A.-B. Tonnel, and J. Pestel
Der p 1-pulsed myeloid and plasmacytoid dendritic cells from house dust mite-sensitized allergic patients dysregulate the T cell response
J. Leukoc. Biol.,
January 1, 2003;
73(1):
91 - 99.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-J. Lee, M. Takei, S. Hori, Y. Inoue, Y. Harada, R. Tanosaki, Y. Kanda, M. Kami, A. Makimoto, S. Mineishi, et al.
The Role of PGE2 in the Differentiation of Dendritic Cells: How Do Dendritic Cells Influence T-Cell Polarization and Chemokine Receptor Expression?
Stem Cells,
September 1, 2002;
20(5):
448 - 459.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. McDowell, M. Marovich, R. Lira, M. Braun, and D. Sacks
Leishmania Priming of Human Dendritic Cells for CD40 Ligand-Induced Interleukin-12p70 Secretion Is Strain and Species Dependent
Infect. Immun.,
August 1, 2002;
70(8):
3994 - 4001.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Q. J. Wang, X.-L. Huang, G. Rappocciolo, F. J. Jenkins, W. H. Hildebrand, Z. Fan, E. K. Thomas, and C. R. Rinaldo Jr
Identification of an HLA A*0201-restricted CD8+ T-cell epitope for the glycoprotein B homolog of human herpesvirus 8
Blood,
May 1, 2002;
99(9):
3360 - 3366.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X.-Q. Zhao, X.-L. Huang, P. Gupta, L. Borowski, Z. Fan, S. C. Watkins, E. K. Thomas, and C. R. Rinaldo Jr.
Induction of Anti-Human Immunodeficiency Virus Type 1 (HIV-1) CD8+ and CD4+ T-Cell Reactivity by Dendritic Cells Loaded with HIV-1 X4-Infected Apoptotic Cells
J. Virol.,
February 22, 2002;
76(6):
3007 - 3014.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. Schonbeck and P. Libby
CD40 Signaling and Plaque Instability
Circ. Res.,
December 7, 2001;
89(12):
1092 - 1103.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. B. Faries, I. Bedrosian, S. Xu, G. Koski, J. G. Roros, M. A. Moise, H. Q. Nguyen, F. H. C. Engels, P. A. Cohen, and B. J. Czerniecki
Calcium signaling inhibits interleukin-12 production and activates CD83+ dendritic cells that induce Th2 cell development
Blood,
October 15, 2001;
98(8):
2489 - 2497.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Fan, X.-L. Huang, L. Borowski, J. W. Mellors, and C. R. Rinaldo Jr.
Restoration of Anti-Human Immunodeficiency Virus Type 1 (HIV-1) Responses in CD8+ T Cells from Late-Stage Patients on Prolonged Antiretroviral Therapy by Stimulation In Vitro with HIV-1 Protein-Loaded Dendritic Cells
J. Virol.,
May 1, 2001;
75(9):
4413 - 4419.
[Abstract]
[Full Text]
|
|
|
| |
